LBP-1c/CP2/LSF gene polymorphism and risk of sporadic Alzheimer's disease [4]

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 75, Issue 1, 2004, Pages 166-168

  Panza, F ^a   D'Introno, A ^a   Colacicco, A M ^a   Capurso, C ^a   Basile, A M ^a   Torres, F ^a   Capurso, A ^a   Solfrizzi, V ^a  

^a UNIVERSITY OF BARI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

GENOMIC DNA;

3' UNTRANSLATED REGION; ADULT; AGED; ALLELE; ALZHEIMER DISEASE; BLOOD SAMPLING; CONFIDENCE INTERVAL; CONTROLLED STUDY; CP2 GENE; DNA EXTRACTION; DNA POLYMORPHISM; DNA PROBE; FEMALE; FLUORESCENCE; GENE; GENE AMPLIFICATION; GENOTYPE; HUMAN; INFORMATION PROCESSING; ITALY; LETTER; MAJOR CLINICAL STUDY; MALE; MATHEMATICAL COMPUTING; ONSET AGE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RANK SUM TEST; STATISTICAL ANALYSIS; STATISTICAL MODEL;

AGE OF ONSET; AGED; ALZHEIMER DISEASE; CASE-CONTROL STUDIES; DNA-BINDING PROTEINS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; RISK FACTORS; RNA-BINDING PROTEINS; TRANSCRIPTION FACTORS;

EID: 0347755467     PISSN: 00223050     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (7)

1. Lambert JC, Goumidi L, Wavrant-De Vrieze F, et al. The transcriptional factor LBP-1c/CP2/LSF gene on chromosome 12 is a genetic determinant of Alzheimer's disease. Hum Mol Genet 2000;9:2275-80.
2. Taylor AE, Yip A, Brayne C, et al. Genetic association of an LBP-1c/CP2/LSF gene polymorphism with late onset Alzheimer's disease. J Med Genet 2001;38:232-3.
3. Luedecking-Zimmer E, DeKosky ST, Nebes R, et al. Association of the 3′ UTR transcription factor LBP-1c/CP2/LSF polymorphism with late-onset Alzheimer's disease. Am J Med Genet 2003;117B:114-17.
4. Lendon C, Craddock N. Is LBP-1C/CP2/LSF a disease-modifying gene far Alzheimer's disease? Lancer 2001;358:1029.
5. McKhann G, Drachman D, Folstein M, et al. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of the Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 1984;34:939-44.
6. Solfrizzi V, Panza F, D'Introno A, et al. Lipoprotein(a), apolipoprotein E genotype, and risk of Alzheimer's disease. J Neurol Neurosurg Psychiatry 2002;72:732-6.
7. Panza F, Solfrizzi V, Torres F, et al. Decreased frequency of apolipoprotein E ε4 allele from northern to southern Europe in Alzheimer's disease patients and centenarians. Neurosci Lett 1999;277:53-6.